Cabrol C
Hôpital de la Pitié, Paris.
Bull Acad Natl Med. 1992 Oct;176(7):1097-107; discussion 1107-10.
Organ transplantation more than a scientific fact is now a social fact. Since the first organ transplantations in France, forty years ago, medicine demonstrated its ability to perform the operation and to obtain (what was more difficult) the tolerance of the graft but medicine so far remains unable to give the material: organs. These organs are given by the donor's relatives when the kidney is concerned and when it is a donation from a living person. But such donation remain strictly limited in our country (less then 5% of the kidney transplantations) due to the risk of moral pressure and commercialization. More often and for the other organs (liver, heart, lung) a the donation is obtained after death, a special and dramatic death: the brain death. The nowadays spectacular results of organ transplantation 70 to 80% survival rate at 10 years with a complete rehabilitation gave a considerable increase on the demand. Unfortunately organ transplantation is the victim of its success, the number of donor's organ being insufficient to satisfy the needs. So in December 1990, 6,055 patients were on the waiting list and only 3,772 (56%) were transplanted. In December 1991, 6,334 patients were on the waiting list and may be only 4,000 could be transplanted. So the difference between the needs and the possibilities is increasing each year with for consequences, the death of 10% of the waiting patients and, for those who could be transplanted, a considerable increase in the waiting period responsible for slow deterioration of their status and less chances of success. The reason of the lack of organs is not due to the lack of brain deaths which are unfortunately too numerous, but to the impossibilities of organ retrieval due to: too advanced age or the presence of a transmissible disease of the donor, lack of medical means in some intensive care units, and family refusal. This refusal is easily understood and due to the very peculiar conditions in which the donation is required: the unexpected death of a loved parent and such a death with some life appearance. To avoid the increasing number of such refusal two actions are possible. One is the modification of the law. The French law is the Caillavet law which requires for organ retrieval, the written permission of the parents for a minor, or for an adult the absence of refusal expressed during his or her life.(ABSTRACT TRUNCATED AT 400 WORDS)
器官移植如今已不只是一个科学事实,更是一个社会事实。自40年前在法国首次进行器官移植以来,医学已证明其具备实施手术的能力,也能实现(更具难度的)移植耐受性,但医学至今仍无法提供所需材料:器官。当涉及肾脏移植且供体为活体时,器官由供体亲属提供。但在我国,这种捐赠仍严格受限(占肾脏移植的比例不到5%),因为存在道德压力和商业化风险。更多情况下,对于其他器官(肝脏、心脏、肺),捐赠是在人死后获得的,即一种特殊且戏剧性的死亡:脑死亡。如今器官移植取得了惊人的成果,10年生存率达70%至80%,且患者能完全康复,这使得需求大幅增加。不幸的是,器官移植因成功而受害,供体器官数量不足以满足需求。所以在1990年12月,有6055名患者在等待名单上,而仅有3772人(56%)接受了移植。1991年12月,有6334名患者在等待名单上,可能只有4000人能够接受移植。因此,需求与可能性之间的差距逐年增大,结果是10%的等待患者死亡,而对于那些能够接受移植的患者,等待时间大幅延长,这导致他们的身体状况逐渐恶化,成功几率降低。器官短缺的原因并非脑死亡数量不足,遗憾的是脑死亡数量过多,而是由于以下原因无法获取器官:供体年龄过大或患有可传播疾病、一些重症监护病房缺乏医疗手段以及家属拒绝。这种拒绝很容易理解,因为捐赠所需的条件非常特殊:亲人意外死亡且这种死亡带有一些生命迹象。为避免此类拒绝情况增多,有两种可行的措施。一种是修改法律。法国现行法律是《凯拉韦法》,该法规定,对于未成年人,器官获取需经其父母书面许可;对于成年人,则需其生前未明确表示拒绝。(摘要截取自400字)